Strategies for Marketing Compliance A Few Thoughts from a Physician’s Point of View
According to the analysts at Gartner, it is possible that a life science company will be fined $1 billion for marketing non-compliance this year.

All pharma companies face a communications crisis that rests on the changing role of the medical sales representative. This evolution has a direct impact on the obligations of the pharma marketing organizations to be both proactive and responsive in helping to protect their organizations from the threat of non-compliance.

What can marketing do? This article offers a few thoughts from a physician’s point of view, written by Jonathan Sackier, M.B., Ch.B., FRCS, FACS who is a regular blogger at

Topics include:

  • Pharma Behaving Badly
  • Good Corporate Citizens All
  • A “Reasonable” $600 Million Fine
  • TABLE: Top 2010 pharmaceutical and medical device settlements relating to off-label marketing.
  • Will 2011 Be DOJ Fine Free?
  • 4 Strategies for Compliance
  • Close the Gap Caused by Downsizing

Read this article now. It’s FREE…

Download PDF file

Issue: Vol. 10, No. 2: 19 January 2011
Word Count: 959

Find other articles in related Topic Areas: